Swiss-based Basilea Pharmaceuticalâs antimicrobial drug gets FDA nodÂ
HQ Team April 4, 2024: The USFDA approved Swiss-based Basilea Pharmaceutica Internationalâs Zevtera injection for the treatment of staphylococcus aureus bloodstream infections and.